Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BIIB

Biogen

$333.77

1.03 (0.31%)

, ESALY

Eisai

$0.00

(0.00%)

15:09
02/19/19
02/19
15:09
02/19/19
15:09
Conference/Events
JPMorgan large-cap biotech analysts to hold an analyst/industry conference call »

Large Cap Biotech Analyst…

BIIB

Biogen

$333.77

1.03 (0.31%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

PFE

Pfizer

$42.41

0.45 (1.07%)

, RHHBY

Roche

$0.00

(0.00%)

09:35
02/19/19
02/19
09:35
02/19/19
09:35
Hot Stocks
Pfizer reports European approval for biosimilar to Avastin »

Pfizer (PFE) announced…

PFE

Pfizer

$42.41

0.45 (1.07%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    Mar

  • 04

    Apr

  • 18

    May

RHHBY

Roche

$0.00

(0.00%)

05:22
02/19/19
02/19
05:22
02/19/19
05:22
Hot Stocks
Genentech granted Priority Review for polatuzumab vedotin/BR combo by FDA »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 04

    Apr

RHHBY

Roche

$0.00

(0.00%)

05:16
02/19/19
02/19
05:16
02/19/19
05:16
Hot Stocks
Genentech NDAs for entrectinib accepted by FDA, granted Priority Review »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 04

    Apr

Thursday
BIIB

Biogen

$321.46

2.03 (0.64%)

07:39
02/14/19
02/14
07:39
02/14/19
07:39
Recommendations
Biogen analyst commentary at Oppenheimer »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ALKS

Alkermes

$32.95

0.64 (1.98%)

, BIIB

Biogen

$321.46

2.03 (0.64%)

07:11
02/14/19
02/14
07:11
02/14/19
07:11
Earnings
Alkermes sees FY19 EPS 25c-43c, consensus 56c »

Sees FY19 revenue…

ALKS

Alkermes

$32.95

0.64 (1.98%)

BIIB

Biogen

$321.46

2.03 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 28

    May

Over a week ago
BIIB

Biogen

$316.95

2.16 (0.69%)

08:02
02/12/19
02/12
08:02
02/12/19
08:02
Recommendations
Biogen analyst commentary at RBC Capital »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

AZN

AstraZeneca

$37.02

0.065 (0.18%)

, BMY

Bristol-Myers

$50.20

0.14 (0.28%)

08:27
02/09/19
02/09
08:27
02/09/19
08:27
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AZN

AstraZeneca

$37.02

0.065 (0.18%)

BMY

Bristol-Myers

$50.20

0.14 (0.28%)

LLY

Eli Lilly

$119.53

2.04 (1.74%)

GSK

GlaxoSmithKline

$41.09

0.52 (1.28%)

JNJ

Johnson & Johnson

$132.35

0.36 (0.27%)

MRK

Merck

$77.53

0.71 (0.92%)

NVS

Novartis

$88.86

0.56 (0.63%)

PFE

Pfizer

$42.23

0.53 (1.27%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$42.64

0.135 (0.32%)

ANTM

Anthem

$304.35

-3.5 (-1.14%)

CNC

Centene

$62.88

-1.015 (-1.59%)

CI

Cigna

$181.09

-4.85 (-2.61%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$298.89

-5.14 (-1.69%)

MOH

Molina Healthcare

$136.89

-0.89 (-0.65%)

UNH

UnitedHealth

$261.69

-7.34 (-2.73%)

WCG

WellCare

$277.19

-2.6 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 14

    Feb

  • 16

    Feb

  • 18

    Feb

  • 19

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 06

    Mar

  • 11

    Mar

  • 18

    Mar

  • 22

    Mar

  • 04

    Apr

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

  • 28

    May

ALKS

Alkermes

$32.50

-1.21 (-3.59%)

, MYL

Mylan

$30.97

-0.11 (-0.35%)

07:42
02/07/19
02/07
07:42
02/07/19
07:42
Recommendations
Alkermes, Mylan, Biogen analyst commentary at Cantor Fitzgerald »

Mylan patent challenge on…

ALKS

Alkermes

$32.50

-1.21 (-3.59%)

MYL

Mylan

$30.97

-0.11 (-0.35%)

BIIB

Biogen

$332.99

-3.88 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

BIIB

Biogen

$332.99

-3.88 (-1.15%)

, MYL

Mylan

$30.97

-0.11 (-0.35%)

05:51
02/07/19
02/07
05:51
02/07/19
05:51
Recommendations
Biogen, Mylan analyst commentary at Mizuho »

Mizuho likes…

BIIB

Biogen

$332.99

-3.88 (-1.15%)

MYL

Mylan

$30.97

-0.11 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.